↓ Skip to main content

Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors

Overview of attention for article published in Endocrine Reviews, June 2011

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter
1 X user
patent
6 patents

Readers on

mendeley
236 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
Published in
Endocrine Reviews, June 2011
DOI 10.1210/er.2010-0016
Pubmed ID
Authors
Abstract

Estrogen signaling pathways, because of their central role in regulating the growth and survival of breast tumor cells, have been identified as suitable and efficient targets for cancer therapies. Agents blocking estrogen activity are already widely used clinically, and many new molecules have entered clinical trials, but intrinsic or acquired resistance to treatment limits their efficacy. The basic molecular studies underlying estrogen signaling have defined the critical role of estrogen receptors (ER) in many aspects of breast tumorigenesis. However, important knowledge gaps remain about the role of posttranslational modifications (PTM) of ER in initiation and progression of breast carcinogenesis. Whereas major attention has been focused on the phosphorylation of ER, many other PTM (such as acetylation, ubiquitination, sumoylation, methylation, and palmitoylation) have been identified as events modifying ER expression and stability, subcellular localization, and sensitivity to hormonal response. This article will provide an overview of the current and emerging knowledge on ER PTM, with a particular focus on their deregulation in breast cancer. We also discuss their clinical relevance and the functional relationship between PTM. A thorough understanding of the complete picture of these modifications in ER carcinogenesis might not only open new avenues for identifying new markers for prognosis or prediction of response to endocrine therapy but also could promote the development of novel therapeutic strategies.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 <1%
Mexico 1 <1%
China 1 <1%
Unknown 232 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 42 18%
Student > Master 37 16%
Researcher 36 15%
Student > Bachelor 21 9%
Student > Doctoral Student 16 7%
Other 30 13%
Unknown 54 23%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 73 31%
Biochemistry, Genetics and Molecular Biology 53 22%
Medicine and Dentistry 24 10%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Chemistry 4 2%
Other 17 7%
Unknown 58 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2025.
All research outputs
#6,623,059
of 31,591,940 outputs
Outputs from Endocrine Reviews
#685
of 1,294 outputs
Outputs of similar age
#32,643
of 152,308 outputs
Outputs of similar age from Endocrine Reviews
#7
of 8 outputs
Altmetric has tracked 31,591,940 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,294 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.4. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,308 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one.